PSD psivida limited

This is from the ASCO...

  1. 496 Posts.
    This is from the ASCO website.

    http://www.asco.org/ASCO/Abstracts+%26+Virtual+Meeting/Abstracts?&vmview=abst_detail_view&confID=53&abstractID=10540

    Conclusion: This study establishes that a novel 32P brachytherapy device is easily deliverable via EUS. In combination with gemcitabine chemotherapy this is a tolerable and potentially effective treatment for locally inoperable pancreatic cancer. A study escalating the radiation dose used is planned.
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.